Home LiteratureArticle Details
PMID: 3007406 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2.

Human immunology ·Vol. 15 ·No. 3 ·1986-03-00 ·Pages 336-43

Segall M, Noreen H, Schluender L, Bach FH

Abstract

DNA restriction fragment length polymorphisms (RFLP) can be easily demonstrated in DNA of cells expressing different DR specificities when class II cDNA probes are used for hybridization. Previous studies of DR4+ homozygous typing cells (HTCs) carrying different Dw subtypes, however, detected no RFLP correlating with subtypes. In contrast, we report here Southern blotting studies of DR2+ HTCs carrying different subtypes which showed RFLP patterns characteristic for each subtype, using both DR beta and DQ beta probes and several restriction enzymes. The RFLP between subtypes of DR2 was, however, appreciably lower than that found between DR specificities.

MeSH Terms
DNA/analysis DNA Restriction Enzymes Ethnicity Gene Frequency Genetic Markers HLA-DR2 Antigen Histocompatibility Antigens Class II/genetics Humans Polymorphism, Genetic
Chemicals
Genetic Markers HLA-DR2 Antigen Histocompatibility Antigens Class II DNA DNA Restriction Enzymes
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Segall M
Noreen H
Schluender L
Bach F H
Article Info
Journal
Human immunology
Abbr.
Hum Immunol
ISSN
0198-8859
Published
1986-03-00
Pages
336-43
Language
English
Region
United States
NLM ID
8010936
Subset
IM
Grants
NIAID NIH HHS · AI 17687 · United States
NIAID NIH HHS · AI 19007 · United States
NIADDK NIH HHS · AM 31342 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com